Vendor, New York, NY
The Trustees of Columbia University in the City of New York
UEI QHF5ZZ114M72, CAGE 3FHD3
50 awards and $6,685,349 obligated between January 10, 2024 and October 19, 2026, 74% under full and open competition, against 7.4 offers on average where reported. 32 of the awards trace back to a SAM.gov solicitation on this site.
Sells to
Awarding agencies by dollars.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $4,516,530 |
| Computer Systems Design ServicesNAICS 541512 | $1,089,350 |
| General Medical and Surgical HospitalsNAICS 622110 | $936,504 |
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $922,694 |
| Testing Laboratories and ServicesNAICS 541380 | $314,311 |
| Research and Development in the Social Sciences and HumanitiesNAICS 541720 | $247,055 |
| Professional, Scientific, and Technical ServicesNAICS 541712 | $81,258 |
| Analytical Laboratory Instrument ManufacturingNAICS 334516 | $29,000 |
| Offices of All Other Miscellaneous Health PractitionersNAICS 621399 | -$28,609 |
| Administration of Public Health ProgramsNAICS 923120 | -$53,958 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 37 |
| Not Competed | 6 |
| Competed Under SAP | 4 |
| Not Competed Under SAP | 3 |
| Delivery Order | 25 |
| Definitive Contract | 12 |
| Purchase Order | 7 |
Hear when The Trustees of Columbia University in the City of New York wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
Contracts The Trustees of Columbia University in the City of New York holds whose performance ends in the next 19 months, by published end date. Each one is a recompete to prepare for.
- Ending
- 4
- Obligated so far
- $1,509,047
- Soonest
- November 29, 2026
The 4 contracts, the office behind each one and the dates are in the workspace. See them
Competes with
Vendors selling research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) to National Institutes of Health, by dollars.
| Leidos Biomedical Research Inc.Frederick, MD | $2,186,369,442 |
| Westat, Inc.Rockville, MD | $760,724,225 |
| Technical Resources International, Inc.Bethesda, MD | $196,391,189 |
| Duke UniversityDurham, NC | $158,758,507 |
| MriglobalKansas City, MO | $117,921,746 |
| The Johns Hopkins UniversityBaltimore, MD | $100,932,043 |
Solicitations it won
SAM.gov opportunities whose award USAspending attributes to this vendor.
- Recipient Epidemiology and Donor Evaluation Study
National Institutes of Health, National Institutes of Health Olao
Award noticeNAICS 541715New York, NY75N92025R00025Awarded to The Trustees of Columbia University in the City of New York for $17,073,000
Posted Sep 255 publications - Solicitation for GAPP Package A for WRAIR-EME
Department of State, U.S. Embassy Tbilisi
Award noticeAnywhere in the US19GG8026P0361Awarded to The Trustees of Columbia University in the City of New York for $29,000
Posted Jul 21 - Prospective Long-Term Follow-Up to COVID-19 Infection with Neurological Manifestations
Centers for Disease Control and Prevention, CDC Office of Acquisition Services
PresolicitationNAICS 541720Atlanta, GA75D301-24-Q-77593Awarded to The Trustees of Columbia University in the City of New York
Posted Mar 14, 2024
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N92024F00001Delivery Order, June 28, 2024, Full and Open Competition | National Institutes of Health NhlbiNational Institutes of Health | Reds-Iv-P Domestic HubsNAICS 541715, PSC AN11 | $1,656,603 |
| 75N93023C00041Definitive Contract, June 26, 2024, Full and Open Competition, 24 offers | National Institutes of Health NiaidNational Institutes of Health | A Glycolipid Adjuvant 7DW8-5 for Malaria VaccinesNAICS 541512, PSC AN12 | $1,089,350 |
| 75N98026F00002Delivery Order, September 25, 2026, Full and Open Competition, 5 offersSolicitation | National Institutes of Health OlaoNational Institutes of Health | Recipient Epidemiology and Donor Evaluation Study (Reds) Regional HubsNAICS 541715, PSC AN11 | $829,129 |
| 75D30124F00002Delivery Order, September 20, 2024, Full and Open Competition, 6 offers | CDC Office of Acquisition ServicesCenters for Disease Control and Prevention | CISA RSV Infants Study (Contributing Site)NAICS 622110, PSC B537 | $767,661 |
| 75N98026F00001Delivery Order, September 25, 2026, Full and Open Competition, 3 offersSolicitation | National Institutes of Health OlaoNational Institutes of Health | Recipient Epidemiology and Donor Evaluation Study (Reds) Center for Transfusion Laboratory Studies (Ctls)NAICS 541715, PSC AN11 | $763,760 |
| 75N98027F00001Delivery Order, October 19, 2026, Full and Open CompetitionSolicitation | National Institutes of Health OlaoNational Institutes of Health | Multi-Ethnic Study of Atherosclerosis (Mesa) - Field Center (Fc) - Task Area B.1, Limited Cohort Examination - Exam 8NAICS 541715, PSC AN12 | $687,021 |
| 75N94025F00001Delivery Order, September 24, 2025, Full and Open Competition, 1 offers | National Institutes of Health NichdNational Institutes of Health | Nichd: R&d: a Phase 2B Study to Evaluate the Efficacy and Safety of Subcutaneous Levonorgestrel Butanoate for Female Contraception: Non-SeveNAICS 541714, PSC AN12 | $539,573 |
| 75N92026F00001Delivery Order, February 9, 2026, Full and Open CompetitionSolicitation | National Institutes of Health NhlbiNational Institutes of Health | Multi-Ethnic Study of Atherosclerosis (Mesa) - Field Center (Fc) - Task Area aNAICS 541715, PSC AN12 | $437,119 |
| W913E524C0028Definitive Contract, September 26, 2024, Full and Open Competition, 1 offersSolicitation | W2R2 Cold RGNS RSCH Eng LabDepartment of the Army | Cso - Automated Solution for Cold Cultivation Culturomics U437N00NAICS 541715, PSC AJ12 | $359,900 |
| 75D30124P18698Purchase Order, April 24, 2024, Not Competed, 1 offersSolicitation | CDC Office of Acquisition ServicesCenters for Disease Control and Prevention | Prospective Long-Term Follow-Up of Covid 19 Infection with Neurological ManifestationsNAICS 541720, PSC AN11 | $249,000 |
| 75F40124C00081Definitive Contract, September 16, 2024, Competed Under SAP, 1 offersSolicitation | FDA Office of Acq Grant SVCSFood and Drug Administration | Cder Neurodevelopmental and Mental Health Outcomes in Preterm Infants: Effects of ExpNAICS 541714, PSC B529 | $237,268 |
| 19VM3025P0594Purchase Order, July 27, 2025, Not Competed, 1 offers | U.S. Embassy HanoiDepartment of State | Hanoinamru-Ip_vircapseq-Vert Probe Set and Twist ReagentsNAICS 541380, PSC 6550 | $190,084 |
| 75N92025F00001Delivery Order, December 18, 2024, Full and Open Competition | National Institutes of Health NhlbiNational Institutes of Health | Multi-Ethnic Study of Atherosclerosis (Mesa), Field Center (Fc): Task Area a - Core OperationsNAICS 541715, PSC AN12 | $186,106 |
| 75F40124F19003Delivery Order, September 26, 2024, Full and Open Competition | FDA Office of Acq Grant SVCSFood and Drug Administration | (Best) Initiative: Community Engagement and Development Initiative for a Convener Organization to Provide the FDA with Support to CollaboratNAICS 611710, PSC R799 | $172,546 |
| 75D30123F00001Delivery Order, August 13, 2024, Full and Open Competition, 10 offers | CDC Office of Acquisition ServicesCenters for Disease Control and Prevention | 2023 Clinical Immunization Safety Assessment (Cisa) Base IDIQNAICS 622110, PSC B537 | $168,843 |
| 75F40123C00211Definitive Contract, August 27, 2024, Full and Open Competition, 1 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | The Objectives of the Proposed Study Are to Examine the Effects of Postnatal Management Approaches (Non-Pharmacological, Including Esc VersuNAICS 541714, PSC AN11 | $83,040 |
| 75N94018F00005Delivery Order, January 16, 2024, Full and Open Competition, 7 offers | National Institutes of Health NichdNational Institutes of Health | Pharmacokinetic/Pharmacodynamic Evaluation of Levonorgestrel Butanoate for Female Contraception Clinical TrialNAICS 541712, PSC AN12 | $81,947 |
| 75F40124C00087Definitive Contract, August 15, 2024, Competed Under SAP, 1 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | Baafda-24-00123, Reference Fy24c3dp2: Systematic Review of Neurodevelopmental Outcome in Vulnerable Pediatric Patient PopulationsNAICS 541714, PSC B529 | $48,448 |
| 75N95023P00861Purchase Order, January 10, 2024, Not Competed Under SAP, 1 offers | National Institutes of Health NidaNational Institutes of Health | In Vivo Testing of a Lead COQ10 Biosynthesis Inhibitor in an Sk-Br-3 Xenograph Mouse ModelNAICS 541380, PSC Q301 | $42,977 |
| 75N93024P01130Purchase Order, September 12, 2024, Competed Under SAP, 1 offers | National Institutes of Health NiaidNational Institutes of Health | TBDC Capseq-Trancriptome Analysis ServiceNAICS 541380, PSC Q301 | $41,250 |
| 19VM3026P0564Purchase Order, August 14, 2026, Not Competed, 1 offers | U.S. Embassy HanoiDepartment of State | Hanoinamru-Ip_reactions Set and Corresponding Twist ReagentsNAICS 541380, PSC 6550 | $40,000 |
| 19GE5026P0062Purchase Order, August 11, 2026, Not Competed, 1 offers | Acquisitions - Rpso FrankfurtDepartment of State | Assay-Specific Reagents and Proprietary Primer/Probe Materials Required to Perform the Columbia/Gapp Vircapseq Workflow at Wrair-Afrims, BanNAICS 334516, PSC 6640 | $29,000 |
| 19GG8026P0361Purchase Order, July 17, 2026, Competed Under SAP, 1 offersSolicitation | U.S. Embassy TbilisiDepartment of State | Wrair_gapp Package aNAICS 621511, PSC 6515 | $29,000 |
| 75N92020F00001Delivery Order, April 12, 2024, Full and Open Competition | National Institutes of Health NhlbiNational Institutes of Health | Mesa Task Area a - Core Operations, Field CenterNAICS 541715, PSC AN12 | $21,133 |
| 75N94020F00001Delivery Order, July 23, 2024, Full and Open Competition, 20 offers | National Institutes of Health NichdNational Institutes of Health | To Assist in the Development of New Contraceptive Products by Providing Services Related to Protocol Review, Protocol Development and ActiviNAICS 541714, PSC AN12 | $14,365 |
| 75D30122F00007Delivery Order, August 22, 2024, Full and Open Competition, 1 offers | CDC Office of Acquisition ServicesCenters for Disease Control and Prevention | Pediatric Covid-19 Vaccination RCTNAICS 621399, PSC AN42 | $1,350 |
| 75A50122C00012Definitive Contract, February 16, 2024, Full and Open Competition, 50 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Trustees of Columbia University Vircapseq: a Platform for Detection of Pandemic Threats and Differential Diagnosis of Infectious Diseases AoNAICS 541714, PSC AN15 | $0 |
| 75N92019F00074Delivery Order, June 12, 2024, Full and Open Competition | National Institutes of Health NhlbiNational Institutes of Health | Cor ChangeNAICS 541715, PSC AN11 | $0 |
| 75N94023F00001Delivery Order, September 25, 2024, Full and Open Competition, 16 offers | National Institutes of Health NichdNational Institutes of Health | Ovaprene Phase 1 - Protocol Finalization, Procurement of Regulatory Approval, and Complete Start-Up Activities for the Ovaprene Vaginal DeviNAICS 541714, PSC AN12 | $0 |
| 80ARC023CA004Definitive Contract, October 7, 2024, Full and Open Competition, 9 offers | NASA Ames Research CenterNational Aeronautics and Space Administration | Contract for Research and Development Work to Extend Longevity of 3D Tissues and Microphysiological Systems for Modeling of Acute and ChroniNAICS 541715, PSC AR11 | $0 |
| 75D30123D18247June 9, 2026, Full and Open Competition, 10 offers | CDC Office of Acquisition ServicesCenters for Disease Control and Prevention | Eo 14398NAICS 622110, PSC B537 | $0 |
| 75F40120D00039May 29, 2025, Full and Open Competition, 2 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | Eoi::{hhs Cost Efficiency Initiative}::eoi. Notice of Termination for Convenience (Complete)NAICS 611710, PSC R799 | $0 |
| 75N92019D00037April 22, 2024, Full and Open Competition, 6 offers | National Institutes of Health NhlbiNational Institutes of Health | EO14042 Reds-Iv-P Domestic HubsNAICS 541715, PSC AN11 | $0 |
| 75N92020D00002May 28, 2024, Full and Open Competition, 6 offers | National Institutes of Health NhlbiNational Institutes of Health | EO14042 Multi-Ethnic Study of Atherosclerosis (Mesa) Field Center (Fc)NAICS 541715, PSC AN12 | $0 |
| 75N92026D00002February 9, 2026, Full and Open Competition, 1 offersSolicitation | National Institutes of Health NhlbiNational Institutes of Health | Multi-Ethnic Study of Atherosclerosis (Mesa) - Field Center (Fc)NAICS 541715, PSC AN12 | $0 |
| 75N94020D00013March 12, 2025, Full and Open Competition, 22 offers | National Institutes of Health NichdNational Institutes of Health | Eoi::defend the Spend::eoi Notice of Termination for ConvenienceNAICS 541714, PSC AN12 | $0 |
| 75N93020C00059Definitive Contract, September 4, 2025, Full and Open Competition, 5 offers | National Institutes of Health NiaidNational Institutes of Health | To Deobligate Fy 2020 5TH Year Funds Characterizing and Improving Humanized Immune System Mouse Models (Imm-His)NAICS 541715, PSC AN12 | -$0 |
| 75N92021F00001Delivery Order, September 4, 2024, Full and Open Competition | National Institutes of Health NhlbiNational Institutes of Health | Multi-Ethnic Study of Atherosclerosis (Mesa) Field Center (Fc) - Task Area B Exam 7NAICS 541715, PSC AN12 | -$0 |
| HHSN27500004Delivery Order, March 1, 2024, Full and Open Competition, 18 offers | National Institutes of Health NichdNational Institutes of Health | Contraceptive Clinical Trial Network - Female Sites - Evaluation of Larcs StudyNAICS 541712, PSC AN12 | -$1 |
| HHSN27500003Delivery Order, November 20, 2024, Full and Open Competition, 12 offers | National Institutes of Health NichdNational Institutes of Health | Clinical Evaluation of Novel Products for Female Contraception: Pilot and Efficacy StudyNAICS 541712, PSC AN12 | -$281 |
| HHSN27500002Delivery Order, September 5, 2024, Full and Open Competition, 20 offers | National Institutes of Health NichdNational Institutes of Health | A Multi-Center, Randomized Study to Evaluate the Pharmacokinetic and Pharmacodynamic Profile, Contraceptive Efficacy and Safety of Daily OraNAICS 541712, PSC AN12 | -$407 |
| 75D30122C14289Definitive Contract, February 29, 2024, Not Competed, 1 offers | CDC Office of Acquisition ServicesCenters for Disease Control and Prevention | Support Translational and Operational Science and Technology Advance to Improve CDCNAICS 541720, PSC R499 | -$1,945 |
| 75F40119C10101Definitive Contract, September 2, 2025, Full and Open Competition, 2 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | BAA for Neurodevelopmental Outcomes in Infants Receiving Opioid-Replacement Pharmacotherapy for Neonatal Opioid Withdrawal Syndrome(Nows), RNAICS 541715, PSC AN22 | -$17,720 |
| HHSD2002012536650005Delivery Order, April 30, 2025, Full and Open Competition, 6 offers | CDC Office of Acquisition ServicesCenters for Disease Control and Prevention | CISA Clinical Covid SupportNAICS 621399, PSC R499 | -$29,959 |
| HHSD200200723654CDefinitive Contract, November 25, 2024, Full and Open Competition, 6 offers | CDC Office of Acquisition ServicesCenters for Disease Control and Prevention | Kenya Hiv Care and TreatmentNAICS 923120, PSC R499 | -$53,958 |
| 75N92021F00001Delivery Order, March 8, 2024, Full and Open Competition | National Institutes of Health NhlbiNational Institutes of Health | Recipient Epidemiology and Donor Evaluation Study IV - Pediatric (Reds-Iv-P) Domestic HubNAICS 541715, PSC AN11 | -$65,247 |
| 75D30123C17500Definitive Contract, February 27, 2025, Not Competed, 1 offers | CDC Office of Acquisition ServicesCenters for Disease Control and Prevention | Lamp StudyNAICS 541715, PSC R499 | -$341,276 |
| 75F40121F19002Delivery Order, June 7, 2024, Full and Open Competition | FDA Office of Acq Grant SVCSFood and Drug Administration | (Best) Initiative: Community Engagement and Development Initiative for a Convener Organization to Provide the FDA with Support to CollaboratNAICS 611710, PSC R799 | -$447,112 |
| 36C24E21N0173Delivery Order, December 29, 2025, Not Competed Under SAP | Rpo EastDepartment of Veterans Affairs | TrainingNAICS 621511, PSC AN11 | -$559,618 |
| 36C24E20N0150Delivery Order, January 8, 2026, Not Competed Under SAP | Rpo EastDepartment of Veterans Affairs | TrainingNAICS 621511, PSC AN11 | -$563,602 |
- Places of performance
- New YorkMarylandGeorgiaWisconsinNorth CarolinaCalifornia
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied ResearchAN11 Health R&D Services; Health Care Services; Basic ResearchB537 Medical and Health StudiesAJ12 General Science And Technology R&D Services; General Science And Technology; Applied ResearchB529 Scientific Data Studies6550 In Vitro Diagnostic Substances, Reagents, Test Kits and Sets
- Transactions
- 119 across 50 awards